Anson Funds Management LP bought a new stake in Zentek Ltd. (NASDAQ:ZTEK - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 154,933 shares of the company's stock, valued at approximately $145,000. Anson Funds Management LP owned 0.15% of Zentek at the end of the most recent reporting period.
Separately, Two Sigma Securities LLC acquired a new position in Zentek in the 4th quarter valued at approximately $31,000. 0.77% of the stock is currently owned by hedge funds and other institutional investors.
Zentek Stock Up 2.6 %
Shares of Zentek stock traded up $0.04 on Thursday, hitting $1.63. 30,196 shares of the company traded hands, compared to its average volume of 43,050. Zentek Ltd. has a 12-month low of $0.50 and a 12-month high of $1.84. The company has a quick ratio of 1.48, a current ratio of 1.83 and a debt-to-equity ratio of 0.01. The company has a market cap of $170.32 million, a PE ratio of -23.31 and a beta of 0.73. The company has a 50-day moving average price of $1.15 and a 200 day moving average price of $1.07.
Zentek (NASDAQ:ZTEK - Get Free Report) last released its quarterly earnings results on Wednesday, February 12th. The company reported ($0.01) earnings per share for the quarter. Zentek had a negative net margin of 16,555.32% and a negative return on equity of 58.13%.
About Zentek
(
Free Report)
Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.
Read More
Before you consider Zentek, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zentek wasn't on the list.
While Zentek currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
